PLX offering history
Every offering-related filing in Protalix BioTherapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 972 filings back to Aug 13, 1996.
| Date | Filing | What it means | |
|---|---|---|---|
| Aug 22, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 22, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 14, 2025 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Apr 28, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 17, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 7, 2023 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Feb 27, 2023 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| May 2, 2022 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 29, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 20, 2022 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Aug 26, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Aug 13, 2021 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 2, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jul 2, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 16, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 11, 2021 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 1, 2020 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Apr 29, 2020 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Apr 29, 2020 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Apr 17, 2020 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Mar 12, 2020 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Apr 12, 2019 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 29, 2019 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 24, 2018 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jul 25, 2017 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 7, 2016 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Dec 18, 2015 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 27, 2015 | S-3/A → | REGISTERED | S-3/A registration — capacity to sell shares, not a sale yet |
| Nov 13, 2015 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 13, 2015 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Sep 18, 2013 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Feb 16, 2012 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Feb 15, 2012 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 18, 2011 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 17, 2011 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Jan 13, 2011 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 10, 2011 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 22, 2008 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 22, 2008 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Oct 25, 2007 | S-3MEF → | REGISTERED | S-3MEF registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
PLX offering FAQ
When did PLX last execute an offering?
Per SEC filings, Protalix BioTherapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2025-08-22. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did PLX last announce or register an offering?
The most recent registration is a S-3/A filed 2025-08-14. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.
Free to use. No account, no card.